These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16611096)

  • 21. Alcoholism: allostasis and beyond.
    Koob GF
    Alcohol Clin Exp Res; 2003 Feb; 27(2):232-43. PubMed ID: 12605072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropeptide y: role in emotion and alcohol dependence.
    Carvajal C; Dumont Y; Quirion R
    CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):181-95. PubMed ID: 16611091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide modulation of addiction: Focus on galanin.
    Genders SG; Scheller KJ; Djouma E
    Neurosci Biobehav Rev; 2020 Mar; 110():133-149. PubMed ID: 29949733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The urocortin 1 neurocircuit: ethanol-sensitivity and potential involvement in alcohol consumption.
    Ryabinin AE; Weitemier AZ
    Brain Res Rev; 2006 Sep; 52(2):368-80. PubMed ID: 16766036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of serotonin outflow by nociceptin/orphaninFQ in dorsal raphe nucleus slices from normal and stressed rats: Role of corticotropin releasing factor.
    Nazzaro C; Marino S; Barbieri M; Siniscalchi A
    Neurochem Int; 2009; 54(5-6):378-84. PubMed ID: 19418633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropeptide systems and schizophrenia.
    LaCrosse AL; Olive MF
    CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):619-32. PubMed ID: 23574175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptors of peptides as therapeutic targets in epilepsy research.
    Dobolyi A; Kékesi KA; Juhász G; Székely AD; Lovas G; Kovács Z
    Curr Med Chem; 2014; 21(6):764-87. PubMed ID: 24251562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting opioid and neurokinin-1 receptors to treat alcoholism.
    Rodriguez FD; Coveñas R
    Curr Med Chem; 2011; 18(28):4321-34. PubMed ID: 21861818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuropeptides in Alzheimer's disease].
    Jiménez-Corral C; Morán-Sánchez JC; Alonso-Navarro H
    Rev Neurol; 2006 Mar 16-31; 42(6):354-9. PubMed ID: 16575772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms.
    Liu X; Weiss F
    J Neurosci; 2002 Sep; 22(18):7856-61. PubMed ID: 12223538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothalamic neuropeptide signaling in alcohol addiction.
    Barson JR; Leibowitz SF
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():321-9. PubMed ID: 25689818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?
    Pomrenze MB; Fetterly TL; Winder DG; Messing RO
    Alcohol Clin Exp Res; 2017 Dec; 41(12):1986-1999. PubMed ID: 28940382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system.
    Cannella N; Economidou D; Kallupi M; Stopponi S; Heilig M; Massi M; Ciccocioppo R
    Neuropsychopharmacology; 2009 Aug; 34(9):2125-34. PubMed ID: 19322167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rats on the grog: novel pharmacotherapies for alcohol craving.
    McGregor IS; Gallate JE
    Addict Behav; 2004 Sep; 29(7):1341-57. PubMed ID: 15345269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The affective dimension of pain as a risk factor for drug and alcohol addiction.
    LeBlanc DM; McGinn MA; Itoga CA; Edwards S
    Alcohol; 2015 Dec; 49(8):803-9. PubMed ID: 26008713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrastructural Characterization of Corticotropin-Releasing Factor and Neuropeptide Y in the Rat Locus Coeruleus: Anatomical Evidence for Putative Interactions.
    Theisen CC; Reyes BAS; Sabban EL; Van Bockstaele EJ
    Neuroscience; 2018 Aug; 384():21-40. PubMed ID: 29775703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol-related behaviors as models for neuropeptide mediation. Introduction to Part IV.
    Erwin VG
    Ann N Y Acad Sci; 1994 Oct; 739():154-5. PubMed ID: 7832468
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting brain angiotensin and corticotrophin-releasing hormone systems interaction for the treatment of mood and alcohol use disorders.
    Sommer WH; Saavedra JM
    J Mol Med (Berl); 2008 Jun; 86(6):723-8. PubMed ID: 18449521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleus incertus corticotrophin-releasing factor 1 receptor signalling regulates alcohol seeking in rats.
    Walker LC; Kastman HE; Koeleman JA; Smith CM; Perry CJ; Krstew EV; Gundlach AL; Lawrence AJ
    Addict Biol; 2017 Nov; 22(6):1641-1654. PubMed ID: 27440230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats.
    Funk CK; Zorrilla EP; Lee MJ; Rice KC; Koob GF
    Biol Psychiatry; 2007 Jan; 61(1):78-86. PubMed ID: 16876134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.